Our initial investment conclusion still stands - buy Blue Prism before the UiPath IPO. We had to recalibrate our view on Blue Prism in terms of market positioning versus market leader UiPath given ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback